Intramyocardial Injection of Autologous Bone Marrow-Derived Ex Vivo Expanded Mesenchymal Stem Cells in Acute Myocardial Infarction Patients is Feasible and Safe up to 5 Years of Follow-up
2013 ◽
Vol 6
(5)
◽
pp. 816-825
◽
2012 ◽
Vol 59
(13)
◽
pp. E478
◽
2005 ◽
Vol 4
(1)
◽
pp. 64-65
2013 ◽
Vol 168
(4)
◽
pp. 3191-3199
◽
2012 ◽
Vol 154
(3)
◽
pp. 354-356
◽
2008 ◽
Vol 29
(15)
◽
pp. 1807-1818
◽